<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myelodsyplastic syndromes are a collection of disorders that affect the hematopoietic development of myeloid cells in the bone marrow </plain></SENT>
<SENT sid="1" pm="."><plain>Although this disorder is curable by way of allogeneic stem cell transplantation, advanced age, limited donor availability, and multiple comorbidities often exclude patients from curative treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Developments using the drugs lenalidomide, <z:chebi fb="0" ids="50131">decitabine</z:chebi>, and <z:chebi fb="0" ids="2038">azacitidine</z:chebi> have offered treatment options to patients ineligible for transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>Nurses remain instrumental in the administration, patient monitoring, and patient education associated with these new therapies </plain></SENT>
</text></document>